相关实验视频

Updated: Jan 12, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

B7-H3:在质瘤的免疫治疗中是一个有希望的目标

Xin-Li Feng¹, Gang Su², Qi Jia¹

¹Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China.

Discover oncology

|October 31, 2025

概括

B7-H3在恶性质瘤中高度表达,促进瘤生长和免疫逃避. 向B7-H3为质瘤治疗提供了一个有希望的新免疫疗法策略.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

质瘤是一种高度异质和恶性脑瘤.
像手术,放射治疗和化疗这样的传统治疗方法都有局限性.
迫切需要新的治疗策略,以有效管理质瘤.

研究的目的:

审查免疫检查点B7-H3在质瘤发展中的作用.
探索B7-H3对质瘤免疫微环境的影响.
讨论针对质瘤的B7-H3向免疫疗法.

主要方法:

在质瘤发生和进展中对B7-H3进行系统审查.
对TCGA,CTPAC,HPA和GEPIA数据库进行分析.
探索B7-H3表达,预后相关性和免疫微环境的相关性.

主要成果:

B7-H3在质瘤中表达高,但在正常脑组织中表达低.
B7-H3表现出免疫抑制功能,并促进质瘤细胞的增殖,迁移和血管生成.
B7-H3表达与质瘤预后和免疫微环境相关.

结论:

B7-H3是质瘤免疫治疗的潜在治疗点.
向B7-H3可能会克服质瘤中的免疫逃生机制.
对基于B7-H3的治疗方法的进一步研究可能会改善质瘤的诊断和治疗.

关键词:

B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 B7-H3 质瘤是一种质瘤.免疫检查站检查站免疫微环境是一个微环境.免疫治疗是一种免疫疗法.

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.